Geographic Availability of Medications for Alcohol Use Disorder in US Treatment Facilities (2017-2023)

This nationwide study tracked trends in availability of evidence-based medications (acamprosate, disulfiram, naltrexone) for alcohol use disorder across US substance use disorder treatment facilities from 2017 to 2023. The research identified geographic disparities and county-level characteristics associated with access to these medications to inform expansion of treatment capacity.